Sumie Koike

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Ryohei Katayama, Luc Friboulet, Sumie Koike et al. · Clinical Cancer Research · 2014 · 286 citations · Full text

Medicine, Oncology, Pharmacology +15

Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2

Satoshi Takagi, Shigeo Sato, Tomoko Oh‐hara et al. · PLoS ONE · 2013 · 207 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

Ryohei Katayama, Yuka Kobayashi, Luc Friboulet et al. · Clinical Cancer Research · 2014 · 200 citations · Full text

Medicine, Oncology, Pharmacology +15

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

Ryohei Katayama, Takuya Sakashita, Noriko Yanagitani et al. · EBioMedicine · 2015 · 142 citations · Full text

Medicine, Oncology, Pharmacology +15

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Ryohei Katayama, Bo Gong, Noriko Togashi et al. · Nature Communications · 2019 · 141 citations · Full text

Medicine, Oncology, Pharmacology +15